MARKET

RDY

RDY

Dr Reddys Labs
NYSE
12.18
+0.07
+0.58%
After Hours: 12.18 0 0.00% 19:30 08/21 EDT
OPEN
12.13
PREV CLOSE
12.11
HIGH
12.23
LOW
12.07
VOLUME
2.02M
TURNOVER
--
52 WEEK HIGH
15.56
52 WEEK LOW
11.28
MARKET CAP
10.17B
P/E (TTM)
28.92
1D
5D
1M
3M
1Y
5Y
1D
Securities Fraud Investigation Into Dr. Reddy’s Laboratories (RDY) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Barchart · 2d ago
Securities Fraud Investigation Into Dr. Reddy’s Laboratories (RDY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Barchart · 3d ago
Dr. Reddy’s Receives USFDA Form 483 for Bachupally Plant After August Inspection
TipRanks · 5d ago
Dr. Reddy’s Receives VAI Classification as USFDA Closes Inspection of U.K. API Plant
TipRanks · 5d ago
Weekly Report: what happened at RDY last week (0810-0814)?
Weekly Report · 5d ago
Dr. Reddy’s says FDA inspection of UK facility ‘officially closed’
TipRanks · 6d ago
RDY SHAREHOLDER ALERT: Dr. Reddy’s Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Barchart · 08/13 19:00
Dr. Reddy’s Announces Resignation of API and Services CEO Deepak Sapra
TipRanks · 08/13 14:17
More
About RDY
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Webull offers Dr Reddy's Laboratories Ltd (ADR) stock information, including NYSE: RDY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDY stock methods without spending real money on the virtual paper trading platform.